4.4 Article

What Is New in Clinical Microbiology Microbial Identification by MALDI-TOF Mass Spectrometry A Paper from the 2011 William Beaumont Hospital Symposium on Molecular Pathology

Journal

JOURNAL OF MOLECULAR DIAGNOSTICS
Volume 14, Issue 5, Pages 419-423

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jmoldx.2012.03.007

Keywords

-

Categories

Funding

  1. Intramural NIH HHS Funding Source: Medline

Ask authors/readers for more resources

Matrix-assisted laser desorption/ionization time-of flight (MALDI-TOF) mass spectrometry (MS) offers the possibility of accurate, rapid, inexpensive identification of bacteria, fungi, and mycobacteria isolated in clinical microbiology laboratories. The procedures for preanalytic processing of organisms and analysis by MALDI-TOF MS are technically simple and reproducible, and commercial databases and interpretive algorithms are available for the identification of a wide spectrum of clinically significant organisms. Although only limited work has been reported on the use of this technique to identify molds, perform strain typing, or determine antibiotic susceptibility results, these are fruitful areas of promising research. As experience is gained with MALDI-TOF MS, it is expected that the databases will be expanded to resolve many of the current inadequate identifications (eg, no identification, genus-level identification) and algorithms for potential misidentification will be developed.. The current lack of Food and Drug Administration approval of any MALDI-TOF MS system for organism identification limits widespread use in the United States. (J Mol Dian 2012, 14:419-423; http://dx.doi.org/10.1016/j.jmoldx.2012.03.007)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available